Bank of Montreal Can Has $4.84 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bank of Montreal Can trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 7.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,368 shares of the financial services provider’s stock after selling 2,830 shares during the period. Bank of Montreal Can’s holdings in iShares Biotechnology ETF were worth $4,835,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Blue Fin Capital Inc. boosted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after purchasing an additional 74 shares in the last quarter. Security National Bank of SO Dak boosted its holdings in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares in the last quarter. SPC Financial Inc. grew its position in shares of iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management increased its stake in shares of iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after acquiring an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC increased its stake in iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 1.2 %

Shares of NASDAQ:IBB opened at $140.00 on Wednesday. iShares Biotechnology ETF has a 52-week low of $121.84 and a 52-week high of $150.57. The business’s 50 day simple moving average is $142.63 and its two-hundred day simple moving average is $142.12.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.